Company Sienna Biopharmaceuticals, Inc. Other OTC
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 26/06/10 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 31/12/15 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 30/11/16 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 30/09/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 30/09/16 |
Founder | 59 | 26/06/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,050,542 | 30,907,542 ( 99.54 %) | 143,000 ( 0.4605 %) | 99.54 % |
Company contact information
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |